Related references
Note: Only part of the references are listed.Rapamycin Pretreatment Rescues the Bone Marrow AML Cell Elimination Capacity of CAR-T Cells
Zhigang Nian et al.
CLINICAL CANCER RESEARCH (2021)
BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemia
Weimin Kong et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
TGFβ Programs Central Memory Differentiation in Ex Vivo-Stimulated Human T Cells
Amina Dahmani et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Human Platelet Lysate Media Supplement Supports Lentiviral Transduction and Expansion of Human T Lymphocytes While Maintaining Memory Phenotype
Emanuele Canestrari et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial
Frederick L. Locke et al.
LANCET ONCOLOGY (2019)
Cholesterol Esterification Enzyme Inhibition Enhances Antitumor Effects of Human Chimeric Antigen Receptors Modified T Cells
Lei Zhao et al.
JOURNAL OF IMMUNOTHERAPY (2018)
Preclinical Optimization of a CD20-specific Chimeric Antigen Receptor Vector and Culture Conditions
Sang Yun Lee et al.
JOURNAL OF IMMUNOTHERAPY (2018)
Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells
Saba Ghassemi et al.
CANCER IMMUNOLOGY RESEARCH (2018)
CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia
Stephanie Vairy et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models
Yuki Kagoya et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
CD19 CAR-T cells of defined CD4+: CD8+ composition in adult B cell ALL patients
Cameron J. Turtle et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W. Lee et al.
LANCET (2015)
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function
Madhusudhanan Sukumar et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
CD8+ CD45RA+ CCR7+ FOXP3+ T Cells with Immunosuppressive Properties: A Novel Subset of Inducible Human Regulatory T Cells
Masakatsu Suzuki et al.
JOURNAL OF IMMUNOLOGY (2012)
Reprogramming CD19-Specific T Cells with IL-21 Signaling Can Improve Adoptive Immunotherapy of B-Lineage Malignancies
Harjeet Singh et al.
CANCER RESEARCH (2011)
Wnt/β-Catenin Signaling in T-Cell Immunity and Cancer Immunotherapy
Luca Gattinoni et al.
CLINICAL CANCER RESEARCH (2010)
Impact of culture medium on the expansion of T cells for immunotherapy
Keisuke Sato et al.
CYTOTHERAPY (2009)
Adoptive transfer of effector CD8(+) T cells derived from central memory cells establishes persistent T cell memory in primates
Carolina Berger et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Dynamic differentiation of activated human peripheral blood CD8+ and CD4+ effector memory T cells
J Schwendemann et al.
JOURNAL OF IMMUNOLOGY (2005)
Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease
L Gorelik et al.
IMMUNITY (2000)
Share Paper
